Cosmetic cross-reference

Ipriflavone

CAS 35212-22-7

Ipriflavone (CAS 35212-22-7) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 2 adverse event associations.

SOURCE NLM DailyMed

Label records

SOURCE EMBL-EBI ChEMBL

Bioactivity

SOURCE DrugCentral

Adverse signals

SOURCE IUPHAR/BPS

PubMed IDs

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Ipriflavone

CAS Number

35212-22-7

UNII

80BJ7WN25Z

InChIKey

SFBODOKJTYAUCM-UHFFFAOYSA-N

ChEMBL ID

CHEMBL165790

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

natural product

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2

Mid-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL165790 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 7 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	AC50	28368.46470588235 nM	99	-
-	Potency	26337.05185185185 nM	43	-
-	IC50	16080.521333333334 nM	14	-
-	EC50	28059 nM	2	-
-	Ki	2491.7 nM	1	-
Prostaglandin G/H synthase 1 Enzyme	IC50	5.531	-	Homo sapiens
Sodium-dependent noradrenaline transporter Transporter	Ki	5.604	-	Homo sapiens

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Ipriflavone used for in pharmaceutical contexts?

Ipriflavone (CAS 35212-22-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Ipriflavone?

Ipriflavone has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Asphyxia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Ipriflavone also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ipriflavone with EU status "permitted".

What clinical phase is Ipriflavone in?

Ipriflavone is rendered with ChEMBL max phase 2.

What bioactivity targets are documented for Ipriflavone?

Ipriflavone has 7 bioactivity rows in this page query. Rendered target entries include Prostaglandin G/H synthase 1, Sodium-dependent noradrenaline transporter.